News

Adagene reported unaudited year-end cash of $74.5 million, guiding runway into late 2027, and outlined a dense slate of...

Ocular Therapeutix has appointed David W. Robinson as Global Chief Commercial Officer and granted him inducement equity awards effective...

INmune Bio outlined two near-term catalysts and a tighter clinical focus in an investor update: a mid‑summer 2026 UK...

Eurobio Scientific reported full-year 2025 revenue of €168 million, up 9% year over year, with comparable pro forma growth...

Agios Pharmaceuticals will report fourth quarter and full-year 2025 results on February 12, 2026 via webcast—an otherwise routine earnings...

BrightInsight has raised $13 million from Eclipse, General Catalyst, Insight Partners, Mayo Clinic, and New Leaf Venture Partners to...

60 Degrees Pharmaceuticals has partnered with Runway Health to expand pre-departure access to Arakoda (tafenoquine), the only once-weekly, broad-spectrum...

Invivyd has enlisted Olympic champion Lindsey Vonn for a national multimedia education campaign on antibodies and infectious disease prevention,...

Entera Bio outlined three near-term milestones: submission of a final Phase 3 protocol to FDA for EB613, its oral...

Liberation Bioindustries has reshuffled its leadership as it approaches the start-up of a 600,000-liter precision fermentation facility in Richmond,...